EKF Diagnostics Holdings plc provided earnings guidance for the year 2016. The company announced that trading in third quarter of the current financial year was materially higher than budget and at a run-rate in excess of market forecasts. As a result the company is now confident of achieving revenues and adjusted EBITDA for 2016 which will exceed the high end of current market forecasts. In addition, the company announced that cash generation during the quarter has been strong and its net debt position has improved considerably. While the company plans to continue investing during fourth quarter and early 2017 in capital expenditure to increase consumables capacity in Germany and to replace equipment in the USA, it now expects to be cash positive within the next 12 months.